Screening histories of invasive breast cancers diagnosed 1989–2006 in the West Midlands, UK: variation with time and impact on 10-year survival

Objectives To examine variations in screening status category with time for 20,862 invasive breast cancers diagnosed in the West Midlands between 1989 and 2006, and to provide 10-year relative survival rates for each category. Method Population-based breast screening was introduced in the West Midlands from 1988. Primary invasive breast cancers diagnosed from 1 April 1989 to 31 March 2006 in women eligible for breast screening were identified from the West Midlands Cancer Intelligence Unit's cancer registration database. A screening status was determined for each case using previously published methodology. Results Screening status rates are affected initially by the gradual rollout of the screening programme and more recently by the need to wait for three years before interval cancers and cancers in lapsed and non-attenders can be identified. In the steady-state period 1994–2003, 40.6% of invasive breast cancers were screen-detected, 36.3% were interval cancers and 11.2% were cancers in non-attenders (NA). Ten-year relative survival was 89.6% for screen-detected breast cancers, 73.3% for interval cancers and 51.9% for cancers in NA. Conclusion The detection of invasive breast cancers by screening has improved over time, with an equivalent reduction in the numbers of interval cancers. This, together with a stable rate of cancers in NA and an improvement in the survival of women with interval cancers, suggests that further improvements in breast cancer mortality can be predicted. International comparisons of interval cancer rates are difficult due to interprogramme differences in the time between screens.

[1]  F. Falcini,et al.  Incidence of interval breast cancers after 650,000 negative mammographics in 13 Italian health districts , 2008, Journal of medical screening.

[2]  M. Wallis,et al.  The West Midlands breast cancer screening status algorithm – methodology and use as an audit tool , 2005, Journal of medical screening.

[3]  Richard J. K. Taylor,et al.  HRT and breast cancer: impact on population risk and incidence. , 2005, European journal of cancer.

[4]  M. Rickard,et al.  Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes , 2002, Journal of medical screening.

[5]  M. Coleman,et al.  Completeness of cancer registration: a new method for routine use , 2000, British Journal of Cancer.

[6]  A. Kavanagh,et al.  Monitoring interval cancers in an Australian mammographic screening programme , 1999, Journal of medical screening.

[7]  Regina C. Elandt-Johnson,et al.  Survival Models and Data Analysis: Elandt-Johnson/Survival , 1999 .

[8]  S. Moss,et al.  Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group. , 1998, Journal of epidemiology and community health.

[9]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[10]  K C Young,et al.  Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme. , 1997, The British journal of radiology.

[11]  R. Blanks,et al.  A Comparison of Two View and One View Mammography in the Detection of Small Invasive Cancers : Results from the National Health Service Breast Screening Programme , 1996, Journal of medical screening.

[12]  L J Yeoman,et al.  Screening interval breast cancers: mammographic features and prognosis factors. , 1996, Radiology.

[13]  C. Camilleri-Ferrante,et al.  Monitoring Interval Cancers in Breast Screening Programmes: The East Anglian Experience , 1995, Journal of medical screening.

[14]  A. Threlfall,et al.  Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region , 1995, BMJ.

[15]  S Shapiro,et al.  Screening: Assessment of current studies , 1994, Cancer.

[16]  D. Ikeda,et al.  Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations. , 1992, AJR. American journal of roentgenology.

[17]  L. Tabár,et al.  Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.

[18]  L. Tabár,et al.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. , 1989, Journal of epidemiology and community health.

[19]  R Holland,et al.  The occurrence of interval cancers in the Nijmegen screening programme. , 1989, British Journal of Cancer.

[20]  N E Day,et al.  Estimating the sensitivity of a screening test. , 1985, Journal of epidemiology and community health.

[21]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[22]  N. L. Johnson,et al.  Survival Models and Data Analysis , 1982 .

[23]  J. Hendriks,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0786 Interval cancers in the Dutch breast cancer screening , 2022 .